). Dr. Glimcher, the first female President and CEO of Dana-Farber, leads the only hospital ranked in the top five nationally by U.S. News & World Report in both adult and pediatric cancer care and ranked as New England’s top ranked cancer center for more than 20 years. She is also Director of Dana-Farber/Harvard Cancer Center and is the Richard and Susan Smith Professor of Medicine at Harvard Medical School. As CEO, Dr. Glimcher has led Dana-Farber through significant growth, opening three new outpatient clinics in the last four years and is leading an effort to build a proposed $1.7 billion independent, adult inpatient cancer center. A proponent of improving access to equitable care, Dr. Glimcher has overseen the establishment of community partnerships to connect patients from underserved communities to cancer prevention, education, diagnosis and care. She is committed to supporting Dana-Farber’s research, which has played a substantive role in developing 51 percent of all FDA-approved cancer drugs in the last five years. She has served as a mentor for research trainees and is a staunch advocate for women in science. Dr. Glimcher is a Member of both the National Academy of Sciences and National Academy of Medicine, is a Fellow of the American Academy of Arts and former President of the American Association of Immunologists.
